v3.26.1
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2022
Dec. 31, 2020
Dec. 31, 2016
Related Party Transaction [Line Items]                    
Investment owned, fair value   $ 0   $ 0            
Research and development expenses   10,826,549 $ 14,521,407 24,896,656 $ 30,612,309          
Affiliated Entity                    
Related Party Transaction [Line Items]                    
Expenses to reimburse                   $ 3,100,000
Collaborative arrangement, term (in years)                   5 years
Contra-research and development expense   $ 41,000 315,000 $ 80,000 601,000          
Plumbline Life Sciences                    
Related Party Transaction [Line Items]                    
Investment owned (in shares)   597,808   597,808            
Non-controlling interest (in percent)   14.50%   14.50%            
Plumbline Life Sciences                    
Related Party Transaction [Line Items]                    
Accounts receivable   $ 0   $ 0   $ 2,100,000        
The Wistar Institute | Affiliated Entity                    
Related Party Transaction [Line Items]                    
Accounts receivable   41,000   41,000   38,000        
Collaborative agreement, amended amount                 $ 12,500,000  
Awarded amount $ 5,600,000         2,600,000 $ 2,400,000 $ 1,200,000    
Awarded option amount       1,000,000.0            
Research and development expenses   38,000 $ 72,000 143,000 $ 72,000          
Accounts payable and accrued liabilities, current   $ 0   $ 0   $ 74,000